Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_assertion type Assertion NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_head.
- NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_assertion description "[These observations raise the possibility that application of PEDF may be helpful in designing new therapeutic strategies for neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease, Alzheimer's disease and brain ischemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_provenance.
- NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_assertion evidence source_evidence_literature NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_provenance.
- NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_assertion SIO_000772 20236058 NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_provenance.
- NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_assertion wasDerivedFrom befree-20150227 NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_provenance.
- NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_assertion wasGeneratedBy ECO_0000203 NP615571.RArzLWIZf6GLjzM4nOUHNBCqTbzWHQGiNMiTtE7KyOu5g130_provenance.